Maryam Oskoui
Investigator
Pediatric Neurologist, Neurophysiologist and Epidemiologist, Montreal Children’s Hospital
Professor, Departments of Pediatrics and Neurology and Neurosurgery, McGill University | Scientist, Research Institute of the McGill University Health Centre
NMD4C Involvement: Pillar 2: Clinical Research
Email MaryamBiography
Dr. Maryam Oskoui is a pediatric neurologist, neurophysiologist and epidemiologist. She is a Distinguished Clinical Research Scholar of the Fonds de Recherche Quebec with a focus in clinical research and clinical trials in pediatric neuromuscular disorders and has contributed to over 100 peer reviewed publications. She is a Principal investigator and SMA lead for INFORM RARE, a Strategy for Patient Oriented Research innovative clinical trial initiative supported by CIHR.
Dr. Oskoui serves as an evidence-based methodologist for the American Academy of Neurology and has contributed to numerous clinical care guidelines. She contributes to the Canadian Neuromuscular community by serving as a member of the Scientific Advisory Committee for Muscular Dystrophy Canada and is past chair of the Canadian Pediatric Neuromuscular Group and the Canadian Neuromuscular Disease Registry’s Spinal Muscular Atrophy Working Group. She is a Board member for the Association des Neurologues du Quebec
Dr. Oskoui completed her medical school and pediatric neurology residency at McGill University (Montreal, Canada), neuromuscular clinical and research fellowship at Columbia University (New York, USA) and Master’s of Science in Clinical Epidemiology at McGill University.
Recent Publications
Kwon, JM, Munell, F, Le Goff, L, Yuge, K, Kato, T, Cances, C et al.. Author Correction: Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial. Nat Med. 2026. PMID:41606122
Socha, PM, Oskoui, M, Hutcheon, JA, Harper, S. A multivariable model for improving the identification of cerebral palsy cases in administrative health data. Ann Epidemiol. 2026.114 26-31 PMID:41539408
Tolchin, B, Goldstein, LH, Reuber, M, Stone, J, Perez, DL, LaFrance, WC Jr et al.. Management of Functional Seizures Practice Guideline Executive Summary: Report of the AAN Guidelines Subcommittee. Neurology. 2026.106 (1)e214466 PMID:41370742
Kwon, JM, Munell, F, Le Goff, L, Yuge, K, Kato, T, Cances, C et al.. Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial. Nat Med. 2025. PMID:41360995
Groulx-Boivin, E, Belzile, A, Nguyen, CÉ, Gauthier, A, Chrestian, N, Michaud-Gosselin, C et al.. Quebec Spinal Muscular Atrophy Newborn Screening Program: The First Year Experience. Int J Neonatal Screen. 2025.11 (4) PMID:41133701
See more on PubMed